Themis Medicare’s VIRALEX® is an effective and safe drug for management of mild to moderate COVID
As the fourth wave of COVID 19 is accompanied by a rise in respiratory viral infections during the rainy season, Themis Medicare’s...
Corporate news, industry updates, business trends, financial updates, market analysis, economic insights, company profiles, industry leaders, investment opportunities, business growth strategies, market research, technology advancements, entrepreneurship, sustainability initiatives, regulatory developments, mergers and acquisitions, emerging markets, global business news, sector-specific news, expert opinions.